HIT Consultant September 16, 2021
Jasmine Pennic

What You Should Know:

– Today, Rune Labs, founded by the former head of Google neuroscience, announced a $22.8M Series A round for the development and delivery of precision medicine for neurodegenerative and psychiatric disorders and diseases like dementia, Alzheimer’s, and Parkinson’s, as well as neurological conditions resulting from COVID infections. The round was led by Eclipse Ventures with participation from current investors including DigiTx and Moment Ventures. Justin Butler, Partner at Eclipse, will join the Rune Labs Board of Directors.

...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Investments, Pharma / Biotech, Precision Medicine, Trends
Exploring the potential of personalized precision medicine for healthcare industry
Putting Patients First by Extending the Reach of World-Class Care
Healthcare's most promising tech
AI In Healthcare: A New Era Of Personalized Patient Care
23andMe reports sales decline a day after announcing plans to cut 40% of workforce

Share This Article